The utility of the Sysmex XE-2100 analyzer's NEUT-X and NEUT-Y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes

被引:55
作者
Furundarena, J. R. [1 ]
Araiz, M. [1 ]
Uranga, M. [1 ]
Sainz, M. R. [1 ]
Agirre, A. [1 ]
Trassorras, M. [1 ]
Uresandi, N. [1 ]
Montes, M. C. [1 ]
Argoitia, N. [1 ]
机构
[1] Donostia Hosp, Hematol Lab, Donostia San Sebastian 20014, Spain
关键词
NEUT-X; NEUT-Y; neutrophil dysplasia; myelodysplastic syndromes; chronic myelomonocytic leukemia;
D O I
10.1111/j.1751-553X.2009.01194.x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
P>The diagnosis of myelodysplastic syndromes (MDS) is based on morphological changes in the blood and bone marrow. The parameters NEUT-X and NEUT-Y of the Sysmex XE-2100 analyzer could help detect neutrophil dysplasia. A control group of 50 patients, along with 50 postpartum patients, 50 anemias, 50 leukopenias, 50 patients with microscopically visible hypergranulated neutrophils and 50 MDS patients were assessed. The NEUT-X and NEUT-Y values (mean +/- SD) for the control group were 1346 +/- 28.2 and 420 +/- 19.3, respectively, with the anemia and leukopenia groups giving similar values. The postpartum and hypergranulated neutrophils groups presented higher values (P < 0.05), whereas the values in the MDS group were 1286 +/- 72.8 and 385 +/- 50.9 (P < 0.05), respectively. There were no differences between the morphological MDS types. The NEUT-X and NEUT-Y values in MDS patients with optical hypogranulation were significantly lower than for MDS patients without optical hypogranulation. NEUT-X and NEUT-Y values lower than 1298 and 398, respectively, would have a specificity for detecting MDS of 94% and 91% and would detect 60% and 56% of cases, respectively, whereas they would detect 75% and 74%, respectively, of MDS cases with optical hypogranulation. NEUT-X and NEUT-Y parameters can be used to detect neutrophil dysplasia arising from MDS and chronic myelomonocytic leukemia.
引用
收藏
页码:360 / 366
页数:7
相关论文
共 7 条
[1]
BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
[2]
BRUNNING RD, 2001, TUMOURS HAEMATOPOIET, P63
[3]
CYMBALISTA F, 2008, SYSM LUNCH S ISLH SY
[4]
CYMBALISTA F, 2005, P SYSM EUR S AUSTR S, P26
[5]
Automation and validation of a rapid method to assess neutrophil and monocyte activation by routine fluorescence flow cytometry in vitro [J].
Linssen, J. ;
Aderhold, S. ;
Nierhaus, A. ;
Frings, D. ;
Kaltschniidt, C. ;
Zaenker, K. .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2008, 74B (05) :295-309
[6]
SCHILLINGER F, 2009, SYSM 5 EUR HAEM S TU, P57
[7]
TKACHUK DC, 2007, WINTROBES ATLAS CLIN, P94